Karen L. Smith
Director · Context Therapeutics Inc.
- 2024
- Jun 26, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Karen L. Smith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 5AM Partners VII, LLC - $445K in SKYE purchases and sales in the last 12 months
- Andrew J. Schwab - $445K in SKYE purchases and sales in the last 12 months
- Nathalie Dubois-Stringfellow - $89K in SGMO purchases and sales in the last 12 months
- Gregory D. Davis - $18K in SGMO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Karen L. Smith?
Karen L. Smith is a corporate insider, tracked as Director of Context Therapeutics Inc. (CNTX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Karen L. Smith last file a Form 4?
The most recent primary Form 4 on record is dated 26 June 2026, one of 7 filings going back to 2024.
Has Karen L. Smith been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($44K) across all tracked filings.
